Haitham Ghunaim
Overview
Explore the profile of Haitham Ghunaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghunaim H, Desin T
Foodborne Pathog Dis
. 2015 Jun;
12(9):733-40.
PMID: 26111256
Foodborne pathogens continue to cause several outbreaks every year in many parts of the world. Among the bacterial pathogens involved, Shiga toxin-producing Escherichia coli, Campylobacter jejuni, and nontyphoidal Salmonella species...
2.
Ghunaim H, Behnke J, Aigha I, Sharma A, Doiphode S, Deshmukh A, et al.
PLoS One
. 2015 Mar;
10(3):e0119268.
PMID: 25781009
Campylobacter infections are a major cause of diarrhoea world-wide and two of the antimicrobials used for their control (erythromycin and ciprofloxacin) have been losing efficacy in recent years. In a...
3.
Ghunaim H, Abu-Madi M, Kariyawasam S
Vet Microbiol
. 2014 Jun;
172(1-2):13-22.
PMID: 24878325
Avian pathogenic Escherichia coli (APEC) is one of the most economically devastating pathogens affecting the poultry industry. This group of extra-intestinal E. coli causes a variety of clinical conditions including...
4.
Azizi A, Ghunaim H, Sirskyj D, Fallahi F, Le H, Kumar A
Hum Vaccin Immunother
. 2013 Mar;
9(7):1445-8.
PMID: 23466688
Oral vaccines have several attractive features; however, due to several challenges, to date, only a limited number of oral vaccines are licensed. Over the past two decades, several oral vehicle...
5.
Ghunaim H, Kumar A, Torres J, Diaz-Mitoma F, Azizi A
Vaccine
. 2011 Jul;
29(35):5950-8.
PMID: 21718739
Despite the extensive efforts towards development of an effective HIV vaccine, major challenges surrounding vaccine design still exist. We have previously developed a unique multivalent HIV-1 candidate vaccine representing hypervariable...
6.
Azizi A, Ghunaim H, Diaz-Mitoma F, Mestecky J
Vaccine
. 2010 Apr;
28(24):4015-26.
PMID: 20412879
The mucosal immune system appears to be a major target of the HIV infection. Therefore, a strong pre-existing anti-HIV immune response in mucosal compartments might be able to prevent HIV...